Bausch Health Companies BHC
NYSE BHC
$5.78 +0.01 (+0.26%)
As of: Sep 29, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Research & Development (2009 - 2026)

Updated

Bausch Health Companies (BHC) posted Research & Development of $173 million for Q2 2026, up 8.8% from $159 million a year earlier and up 6.1% from the prior quarter.

Analysis

Bausch Health Companies (BHC) Research & Development (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Bausch Health Companies was $663 million, up 8.5% year-over-year; for FY2025, it was $629 million, up 2.1% from FY2024.

  • Annual Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 6.8% (FY2020 to FY2025).
  • In prior years, Bausch Health Companies' Research & Development was $616 million in FY2024 (+2.0%), $604 million in FY2023 (+14.2%), $529 million in FY2022 (+13.8%) and $465 million in FY2021 (+2.9%).
  • The Q2 2026 figure stands as the highest quarterly Research & Development in data going back to Q2 2009.
  • On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 4.3%.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q2 2023, with growth of 22.8%; the weakest was Q1 2025, with a decline of 5.3%.
  • According to Business Quant data, Research & Development for the three prior quarters was $163 million (Q1 2026), $161 million (Q4 2025) and $166 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Bausch Health Companies 2.16 Bn -2.61 Bn 2.08 Bn 173.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 173.00 Mn
Mar 31, 2026 163.00 Mn
Dec 31, 2025 161.00 Mn
Sep 30, 2025 166.00 Mn
Jun 30, 2025 159.00 Mn
Mar 31, 2025 143.00 Mn
Dec 31, 2024 163.00 Mn
Sep 30, 2024 146.00 Mn
Jun 30, 2024 156.00 Mn
Mar 31, 2024 151.00 Mn
Dec 31, 2023 152.00 Mn
Sep 30, 2023 153.00 Mn
Jun 30, 2023 156.00 Mn
Mar 31, 2023 143.00 Mn
Dec 31, 2022 142.00 Mn
Sep 30, 2022 133.00 Mn
Jun 30, 2022 127.00 Mn
Mar 31, 2022 127.00 Mn
Dec 31, 2021 117.00 Mn
Sep 30, 2021 121.00 Mn
API Access

Bausch Health Companies Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=BHC&period=max&api_key=YOUR_API_KEY